<DOC>
	<DOCNO>NCT02429531</DOCNO>
	<brief_summary>Specific polysaccharide antibody deficiency ( SPAD ) primary immunodeficiency characterize deficient antibody production capsular polysaccharide normal total immunoglobulin level . Patients suffer recurrent ear-nose throat infection lung infection . SPAD also occur part primary immunodeficiency affect component immune system . Diagnosis SPAD hamper difficulty interpretation Pneumovax 23 antibody response . The purpose study ass diagnostic value Typhim Vi antibody response allohemagglutinin titer alternative Pneumovax 23 response detect polysaccharide specific antibody deficiency .</brief_summary>
	<brief_title>Polysaccharide Antibody Response Study</brief_title>
	<detailed_description>Healthy control ( n = 100 ) patient suspect SPAD ( n = 100 ) immunize Pneumovax 23 Typhim Vi ( age 18 month - 55 year ) . Analyses anti-pneumococcal polysaccharide antibody anti-Vi antibody perform 3-4 week vaccination . Also bloodgroup anti-A/anti-B assess . Relevant clinical information ( ENT infection , lung infection , bronchiectasis , invasive infection ) obtain patient file history note Case Report Form . The diagnostic performance Typhim Vi response allohemagglutinins analyzed calculate sensitivity , specificity , predictive value , likelihood ratio Receiver Operating Characteristic curve Typhim Vi allohemagglutinins use pneumococcal antibody response reference standard . The association low Typhim Vi response low allohemagglutinins clinical sign polysaccharide antibody deficiency study multiple logistic regression .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Assessment polysaccharide antibody response indicate clinical care patient ( healthy volunteer ) Informed consent give History serious adverse reaction vaccine Vaccination Typhim Vi Pneumovax 23 5 year prior study ( Potential ) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pneumovax 23</keyword>
	<keyword>Typhim Vi</keyword>
	<keyword>allohemagglutinins</keyword>
</DOC>